Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19520656 | 0.93 | PRMT1 (0.59) | ATMPRMT1LMNAKMT2ATHRB | |
| SCHEMBL3185096 | 0.92 | ATM (0.46) | ATMPRMT1LMNAKMT2ATHRB | |
| SCHEMBL8519057 | 0.91 | PRMT1 (0.63) | PRMT1LMNAKMT2ATHRBBLM | |
| SCHEMBL7436387 | 0.91 | PRMT1 (0.63) | PRMT1LMNAKMT2ATHRBBLM | |
| SCHEMBL7444117 | 0.86 | PRMT1 (0.52) | ATMPRMT1LMNAKMT2ATHRB | |
| SCHEMBL385127 | 0.86 | ECE1 (0.58) | LMNAKMT2ATHRBBLMNPSR1 | |
| SCHEMBL1769661 | 0.84 | ATM (0.55) | ATMPRMT1LMNAKMT2ATHRB | |
| SCHEMBL17177667 | 0.84 | ALDH1A1 (0.41) | ATMKMT2ATSHRMEN1ALDH1A1 | |
| SCHEMBL9717419 | 0.83 | ECE1 (0.60) | ATMPRMT1LMNAKMT2ATSHR | |
| SCHEMBL2806091 | 0.83 | ATM (0.57) | ATMPRMT1LMNAKMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121577901-A | Urine metabolism marker combination for distinguishing benign kidney diseases from kidney cancers and application thereof | 哈尔滨脉图精准技术有限公司 | 2026-02-27 | — | — | CN | claimed |
| CN-121577901-A | Urine metabolism marker combination for distinguishing benign kidney diseases from kidney cancers and application thereof | 哈尔滨脉图精准技术有限公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-121577901-A | Urine metabolism marker combination for distinguishing benign kidney diseases from kidney cancers and application thereof | 哈尔滨脉图精准技术有限公司 | 2026-02-27 | — | — | CN | disclosed |
| US-20220007684-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Anipha Technologies Pty Ltd (AU) | 2022-01-13 | — | — | US | disclosed |
| US-20220007684-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Anipha Technologies Pty Ltd (AU) | 2022-01-13 | — | — | US | disclosed |
| US-11185594-B2 | (Anti-HER2 antibody)-drug conjugate | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2021-11-30 | — | — | US | disclosed |
| EP-3878287-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Peng, Xianfeng (CN) | 2021-09-15 | — | — | EP | disclosed |
| EP-3878287-A1 | APPLICATION OF ACYLATED DERIVATIVE OF AMINO ACID IN PREPARATION OF ANIMAL FEED ADDITIVE | Peng, Xianfeng (CN) | 2021-09-15 | — | — | EP | disclosed |
| CN-111629602-A | Application of acylated derivative of amino acid in preparation of animal feed additive | 黄华成 | 2020-09-04 | — | — | CN | disclosed |
| US-20200276275-A1 | Therapies for Obesity, Diabetes and Related Indications | PALATIN TECHNOLOGIES INC (US) | 2020-09-03 | — | — | US | disclosed |
| US-20120178701-A1 | Melanocortin Receptor-Specific Peptides | PALATIN TECHNOLOGIES, INC. (US) | 2012-07-12 | — | — | US | disclosed |
| EP-2440227-A2 | MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | Palatin Technologies, Inc. (US) | 2012-04-18 | — | — | EP | disclosed |
| WO-2010144344-A2 | MELANOCORTIN RECEPTOR-SPECIFIC PEPTIDES | PALATIN TECHNOLOGIES, INC. (US) | 2010-12-16 | — | — | WO | disclosed |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2007-02-22 | — | — | US | disclosed |
| EP-0475160-B2 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 2004-07-14 | — | — | EP | disclosed |
| US-6165500-A | Preparation for the application of agents in mini-droplets | IDEA AG (DE) | 2000-12-26 | — | — | US | disclosed |
| WO-2000008202-A2 | 3-METHYLIDENYL-2-INDOLINONE MODULATORS OF PROTEIN KINASE | SUGEN, INC. (US) | 2000-02-17 | — | — | WO | disclosed |
| EP-0475160-B1 | Preparation for drug application in minute droplet form | IDEA AG (DE) | 1996-02-14 | — | — | EP | disclosed |
| EP-0475160-A1 | Preparation for drug application in minute droplet form | Cevc, Gregor, Prof. Dr. (DE) | 1992-03-18 | — | — | EP | disclosed |
| US-4900730-A | USING CHELATING AGENT AND SOLVENT; HIGH OSMOTIC PRESSURE | TOYO JOZO CO., LTD. (JP) | 1990-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200276275-A1 | Therapies for Obesity, Diabetes and Related Indications | MC4R, GLP1R, MC3R | ATM 4576/4885PRMT1 3486/4885LMNA 3903/4885 |
| US-11185594-B2 | (Anti-HER2 antibody)-drug conjugate | ERBB2, EGFR, LANCL2 | ATM 1345/4885PRMT1 3228/4885LMNA 139/4885 |
| US-20120178701-A1 | Melanocortin Receptor-Specific Peptides | MC1R, MC3R, MC5R | ATM 4780/4885PRMT1 228/4885LMNA 3579/4885 |
| US-20070042030-A1 | Preparation for the application of agents in mini-droplets | FABP4, NPC1L1, LIPA | ATM 4581/4885PRMT1 4225/4885LMNA 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.